early detection Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test. Freenome Nets $290M Investment From Roche The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types. Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium New companies claimed stakes during the year, established firms solidified their plans and data, and Grail launched the first genomic multi-cancer early detection test. Burning Rock Details Launch Plans for Three New Oncology Assays in 2022 Premium The company said it expects to launch an in-licensed lung cancer treatment decision assay next year, alongside its own multi-cancer early detection and MRD products. BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy The company is developing a metabolomic assay for early detection of lung cancer with academic collaborators at the University of Alberta. Nov 5, 2021 Pancreatic Cancer Application Provides First Toehold for Biological Dynamics in Clinical Testing Premium Oct 28, 2021 Veracyte Builds Data for Lung Cancer Swab Test, Begins Limited Launch Premium Sep 30, 2021 Pancreatic Cancer Data Preview Freenome's Plans for Expanded Cancer Detection Assay Premium Sep 1, 2021 Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection Premium Aug 27, 2021 Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech Premium Aug 18, 2021 Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny Aug 6, 2021 Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay Premium Aug 5, 2021 Guardant Health Q2 Revenues Grow 39 Percent Aug 5, 2021 Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test Premium Jul 29, 2021 Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project Jul 20, 2021 Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant Jul 1, 2021 Canadian Liquid Biopsy Startup Adela to Pursue Cancer Early Detection Tests Premium Jun 21, 2021 Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium May 26, 2021 Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay Premium May 25, 2021 Burning Rock Q1 Revenues Rise 58 Percent May 19, 2021 Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing Premium May 13, 2021 Viome Forays Outside Molecularly Informed DTC Wellness Testing With Oral Cancer Assay Premium Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 11, 2021 NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths Load More Breaking News Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools SeqOne Genomics Closes €20M Series A Financing NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources The Scan For STEM Students to Stay New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports. To Inform or Not, To Know or Not The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information. Rapid Test Studies Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says. PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.